KEQU
KEQU
NASDAQ · Health Care

Kewaunee Scientific Cp

$35.70
-0.24 (-0.67%)
Financial Highlights (FY 2026)
Revenue
286.39M
Net Income
9.77M
Gross Margin
28.5%
Profit Margin
3.4%
Rev Growth
+8.7%
D/E Ratio
0.63
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 28.5% 28.5% 50.5% 50.5%
Operating Margin 5.9% 5.3% 10.7% 9.9%
Profit Margin 3.4% 3.2% 9.0% 9.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 286.39M 263.44M 59.81M 50.24M
Gross Profit 81.68M 75.13M 30.19M 25.36M
Operating Income 16.98M 14.06M 6.40M 4.98M
Net Income 9.77M 8.09M 5.37M 4.75M
Gross Margin 28.5% 28.5% 50.5% 50.5%
Operating Margin 5.9% 5.3% 10.7% 9.9%
Profit Margin 3.4% 3.2% 9.0% 9.5%
Rev Growth +8.7% +8.7% +13.1% -4.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 19.89M 19.89M 32.14M 29.26M
Total Equity 31.79M 31.79M 76.20M 84.12M
D/E Ratio 0.63 0.63 0.42 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 23.35M 20.41M 8.28M 7.47M
Free Cash Flow — — 3.50M 3.36M